Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $22.8 million.

  • Oncology Institute's Accumulated Expenses rose 4760.95% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year increase of 4760.95%. This contributed to the annual value of $21.1 million for FY2024, which is 5070.73% up from last year.
  • Per Oncology Institute's latest filing, its Accumulated Expenses stood at $22.8 million for Q3 2025, which was up 4760.95% from $22.9 million recorded in Q2 2025.
  • Oncology Institute's 5-year Accumulated Expenses high stood at $23.4 million for Q1 2025, and its period low was $80000.0 during Q1 2021.
  • For the 5-year period, Oncology Institute's Accumulated Expenses averaged around $14.3 million, with its median value being $14.5 million (2022).
  • Per our database at Business Quant, Oncology Institute's Accumulated Expenses skyrocketed by 1804500.0% in 2022 and then tumbled by 2120.52% in 2023.
  • Oncology Institute's Accumulated Expenses (Quarter) stood at $13.9 million in 2021, then grew by 4.82% to $14.6 million in 2022, then dropped by 4.1% to $14.0 million in 2023, then skyrocketed by 50.71% to $21.1 million in 2024, then rose by 8.02% to $22.8 million in 2025.
  • Its Accumulated Expenses was $22.8 million in Q3 2025, compared to $22.9 million in Q2 2025 and $23.4 million in Q1 2025.